Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX)

CUSIP: G7709Q104

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Class A Ordinary Shares, par value $0.0001 per share
Shares outstanding
424,966,351
Total 13F shares
270,383,631
Share change
+2,206,105
Total reported value
$10,536,275,796
Put/Call ratio
10%
Price per share
$38.96
Number of holders
272
Value change
+$82,755,109
Number of buys
175
Number of sells
91

Quarterly Holders Quick Answers

What is CUSIP G7709Q104?
CUSIP G7709Q104 identifies RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX) as of Q1 2022

As of 31 Mar 2022, Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX) was held by 272 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 270,383,631 shares. The largest 10 holders included MORGAN STANLEY, VANGUARD GROUP INC, FMR LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Inc., VIKING GLOBAL INVESTORS LP, STATE STREET CORP, SIGULER GUFF ADVISERS, LLC, JPMORGAN CHASE & CO, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 272 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.